VitalConnect key facts
as of Oct 2026- Developer of wearable biosensor technology designed to continuously monitor and record patients' vital signs.
- VitalConnect is valued at approximately $463.0M as of Oct 2026 (last reported valuation).
- It has raised $382.9M; the latest was Later Stage VC ($100.0M) in Feb 2025.
- Notable investors include Revelation Partners, Ally Bridge Group, EW Healthcare Partners, Asahi Kasei Corporate Venture Capital, Baxter Ventures — 10 tracked in total.
- Status: Privately Held (backing).
VitalConnect's last reported valuation, Feb 2025. Nothing priced has surfaced since.
- ·Watch VitalConnect: the Monday email on marks, rounds and moves
VitalConnect funding rounds
No funding rounds for VitalConnect are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
VitalConnect valuation
VitalConnect's last reported valuation was $463 million in Feb 2025. No priced round, secondary trade or fund mark has surfaced since.
VitalConnect investors
10 investors are on record for VitalConnect, including Revelation Partners, Ally Bridge Group, EW Healthcare Partners and Asahi Kasei Corporate Venture Capital.
About VitalConnect
Developer of wearable biosensor technology designed to continuously monitor and record patients' vital signs. The company's technology uses an adhesive patch to stick to the body and leverages biomedical engineering, data analytics, and chip design which can be displayed on mobile devices or computer systems, enabling healthcare professionals to respond immediately to urgent situations and access unprecedented insight into patient health to aid in critical decisions.
- Sector
- Healthcare
- HQ
- San Jose, CA, United States
- Founded
- 2011
- Employees
- 183
- Website
- vitalconnect.com/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.